TEVA logo

TEVA Total expenses

Annual total expenses:

$13.18B+$530.00M(+4.19%)
December 31, 2024

Summary

  • As of today (May 30, 2025), TEVA annual total expenses is $13.18 billion, with the most recent change of +$530.00 million (+4.19%) on December 31, 2024.
  • During the last 3 years, TEVA annual total expenses has risen by +$402.00 million (+3.15%).
  • TEVA annual total expenses is now -26.20% below its all-time high of $17.86 billion, reached on December 31, 2017.

Performance

TEVA Total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

Quarterly total expenses:

$3.19B-$123.00M(-3.72%)
March 31, 2025

Summary

  • As of today (May 30, 2025), TEVA quarterly total expenses is $3.19 billion, with the most recent change of -$123.00 million (-3.72%) on March 31, 2025.
  • Over the past year, TEVA quarterly total expenses has increased by +$8.00 million (+0.25%).
  • TEVA quarterly total expenses is now -39.62% below its all-time high of $5.28 billion, reached on December 31, 2016.

Performance

TEVA Quarterly total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

Total expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

TEVA Total expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+4.2%+0.3%
3 y3 years+3.1%+7.1%
5 y5 years-7.0%-6.8%

TEVA Total expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+7.7%-4.9%+9.0%
5 y5-year-7.0%+7.7%-14.8%+9.0%
alltimeall time-26.2%>+9999.0%-39.6%+1556.3%

TEVA Total expenses History

DateAnnualQuarterly
Mar 2025
-
$3.19B(-3.7%)
Dec 2024
$13.18B(+4.2%)
$3.31B(-1.2%)
Sep 2024
-
$3.35B(-0.0%)
Jun 2024
-
$3.35B(+5.4%)
Mar 2024
-
$3.18B(+0.2%)
Dec 2023
$12.65B(+3.4%)
$3.17B(+2.4%)
Sep 2023
-
$3.10B(-4.2%)
Jun 2023
-
$3.23B(+2.5%)
Mar 2023
-
$3.15B(-2.9%)
Dec 2022
$12.23B(-4.3%)
$3.25B(+11.2%)
Sep 2022
-
$2.92B(-5.6%)
Jun 2022
-
$3.09B(+4.0%)
Mar 2022
-
$2.97B(-9.2%)
Dec 2021
$12.78B(-6.0%)
$3.27B(+3.1%)
Sep 2021
-
$3.18B(+2.5%)
Jun 2021
-
$3.10B(-4.0%)
Mar 2021
-
$3.23B(-13.6%)
Dec 2020
$13.60B(-4.0%)
$3.74B(+14.7%)
Sep 2020
-
$3.26B(+2.4%)
Jun 2020
-
$3.18B(-6.9%)
Mar 2020
-
$3.42B(-9.9%)
Dec 2019
$14.17B(-8.0%)
$3.80B(+12.7%)
Sep 2019
-
$3.37B(-4.1%)
Jun 2019
-
$3.51B(+0.7%)
Mar 2019
-
$3.49B(+1.4%)
Dec 2018
$15.40B(-13.8%)
$3.44B(-11.1%)
Sep 2018
-
$3.87B(-2.1%)
Jun 2018
-
$3.96B(-4.3%)
Mar 2018
-
$4.13B(+4.9%)
Dec 2017
$17.86B(+3.2%)
$3.94B(-16.4%)
Sep 2017
-
$4.71B(+1.6%)
Jun 2017
-
$4.64B(+1.6%)
Mar 2017
-
$4.57B(-13.4%)
Dec 2016
$17.30B(+18.0%)
$5.28B(+12.8%)
Sep 2016
-
$4.67B(+23.1%)
Jun 2016
-
$3.80B(+7.0%)
Mar 2016
-
$3.55B(-6.7%)
Dec 2015
$14.66B(-7.1%)
$3.81B(+8.5%)
Sep 2015
-
$3.51B(-3.5%)
Jun 2015
-
$3.63B(-1.9%)
Mar 2015
-
$3.71B(-7.0%)
Dec 2014
$15.78B(-3.5%)
$3.98B(+2.0%)
Sep 2014
-
$3.90B(-1.2%)
Jun 2014
-
$3.95B(+0.2%)
Mar 2014
-
$3.94B(-10.3%)
Dec 2013
$16.35B(+1.3%)
$4.39B(+8.7%)
Sep 2013
-
$4.04B(+1.9%)
Jun 2013
-
$3.97B(+0.7%)
Mar 2013
-
$3.94B(-7.9%)
Dec 2012
$16.14B(+12.8%)
$4.28B(+9.7%)
Sep 2012
-
$3.90B(-0.8%)
Jun 2012
-
$3.93B(-2.3%)
Mar 2012
-
$4.03B(-10.9%)
Dec 2011
$14.30B(+20.8%)
$4.52B(+38.6%)
Sep 2011
-
$3.26B(-2.5%)
Jun 2011
-
$3.34B(+5.0%)
Mar 2011
-
$3.18B(-4.1%)
Dec 2010
$11.84B
$3.32B(+10.4%)
Sep 2010
-
$3.01B(+10.6%)
Jun 2010
-
$2.72B(-2.2%)
DateAnnualQuarterly
Mar 2010
-
$2.78B(-3.8%)
Dec 2009
$10.83B(+10.4%)
$2.89B(+7.1%)
Sep 2009
-
$2.70B(+2.0%)
Jun 2009
-
$2.65B(+2.0%)
Mar 2009
-
$2.60B(-26.8%)
Dec 2008
$9.82B(+40.0%)
$3.55B(+61.8%)
Sep 2008
-
$2.19B(+0.3%)
Jun 2008
-
$2.19B(+15.4%)
Mar 2008
-
$1.89B(-1.1%)
Dec 2007
$7.01B(+11.1%)
$1.92B(+11.7%)
Sep 2007
-
$1.72B(-1.9%)
Jun 2007
-
$1.75B(+7.0%)
Mar 2007
-
$1.63B(-11.9%)
Dec 2006
$6.31B(+60.3%)
$1.85B(+18.7%)
Sep 2006
-
$1.56B(+4.3%)
Jun 2006
-
$1.50B(+9.5%)
Mar 2006
-
$1.37B(+31.4%)
Dec 2005
$3.94B(+8.7%)
$1.04B(+3.5%)
Sep 2005
-
$1.01B(+9.4%)
Jun 2005
-
$918.60M(-5.7%)
Mar 2005
-
$974.00M(-1.3%)
Dec 2004
$3.62B(+51.5%)
$986.90M(+6.2%)
Sep 2004
-
$929.60M(+5.7%)
Jun 2004
-
$879.30M(+6.2%)
Mar 2004
-
$828.20M(+15.8%)
Dec 2003
$2.39B(+19.9%)
$715.50M(+16.2%)
Sep 2003
-
$615.50M(+27.6%)
Jun 2003
-
$482.50M(-16.5%)
Mar 2003
-
$578.10M(-1.6%)
Dec 2002
$1.99B(+17.3%)
$587.60M(+15.3%)
Sep 2002
-
$509.70M(+10.7%)
Jun 2002
-
$460.40M(+5.4%)
Mar 2002
-
$436.90M(-4.0%)
Dec 2001
$1.70B(+23.7%)
$455.31M(+12.0%)
Sep 2001
-
$406.70M(-4.7%)
Jun 2001
-
$426.74M(+3.6%)
Mar 2001
-
$412.02M(+20.3%)
Dec 2000
$1.37B(+35.4%)
$342.52M(-8.8%)
Sep 2000
-
$375.63M(+0.1%)
Jun 2000
-
$375.16M(+33.3%)
Mar 2000
-
$281.34M(+12.6%)
Dec 1999
$1.01B(+11.3%)
$249.84M(-7.3%)
Sep 1999
-
$269.50M(+8.2%)
Jun 1999
-
$249.00M(+0.9%)
Mar 1999
-
$246.70M(+28.3%)
Dec 1998
$912.19M(-3.3%)
$192.29M(-27.1%)
Sep 1998
-
$263.60M(+17.9%)
Jun 1998
-
$223.50M(-4.1%)
Mar 1998
-
$233.00M
Dec 1997
$943.10M(+14.4%)
-
Dec 1996
$824.50M(+16.6%)
-
Dec 1995
$707.10M(+13.2%)
-
Dec 1994
$624.80M(+50.9%)
-
Dec 1993
$414.00M(+21.2%)
-
Dec 1992
$341.60M(+24.2%)
-
Dec 1991
$275.00M(-4.7%)
-
Dec 1990
$288.70M(+21.9%)
-
Dec 1989
$236.90M(+25.6%)
-
Dec 1988
$188.60M(+56.8%)
-
Mar 1987
$120.30M(+51.7%)
-
Mar 1986
$79.30M
-

FAQ

  • What is Teva Pharmaceutical Industries Limited annual total expenses?
  • What is the all time high annual total expenses for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual total expenses year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly total expenses?
  • What is the all time high quarterly total expenses for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly total expenses year-on-year change?

What is Teva Pharmaceutical Industries Limited annual total expenses?

The current annual total expenses of TEVA is $13.18B

What is the all time high annual total expenses for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual total expenses is $17.86B

What is Teva Pharmaceutical Industries Limited annual total expenses year-on-year change?

Over the past year, TEVA annual total expenses has changed by +$530.00M (+4.19%)

What is Teva Pharmaceutical Industries Limited quarterly total expenses?

The current quarterly total expenses of TEVA is $3.19B

What is the all time high quarterly total expenses for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly total expenses is $5.28B

What is Teva Pharmaceutical Industries Limited quarterly total expenses year-on-year change?

Over the past year, TEVA quarterly total expenses has changed by +$8.00M (+0.25%)
On this page